Biosimulation Market (2022 Edition) - Analysis By Component (Software, Service), Application (Drug Discovery, Pre-Clinical, Clinical), End-User, By Region, By Country: Market Insights and Forecast (2018-2028)

Report
270 Pages
November 2022
Region: Global
Azoth Analytics
ID: 5700407

According to a research report published in November 2022, the Global Biosimulation Market was valued at USD 3011.50 Million in the year 2021. Biosimulation helps to increase probability of success in human clinical trials, the most expensive part of drug development. Biosimulation helps to optimize dosing for different populations for enhanced safety and efficacy. New drugs can cause significant increases in retail spending because they are more expensive, in high demand, or both. Currently, In-Silico methods are outpacing various stages of drug discovery, particularly in biomedicine sciences.

Biosimulation drug discovery offers numerous opportunities for error elimination through computer simulation, which can improve drug performance and accuracy. In the forthcoming years, there will be more potential for the Biosimulation market to flourish due to the expanding applications and rising use of personalized medicine and biosimulation solutions for the development of paediatric drugs. Companies around the world use key strategies such as Component launches, business expansions, mergers and acquisitions, patents and approvals, agreements and collaborations.

The key software methods for developing a drug are structure-based drug design, molecular modelling, structure-based virtual screening, ligand interaction, and molecular dynamics. New technologies such as virtual reality and artificial intelligence (AI) are expanding the opportunities for drug discovery. Americas has the lucrative growth in the Biosimulation industry and the United States remains the country with the earliest launches accounting for 72 NASs launched in 2021.

Scope of the Report

The report presents the analysis of the Biosimulation market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.
The report analyses the Biosimulation Market by Value (USD Million).
The report analyses the Biosimulation Market by Component (Software, Service).
The report analyses the Biosimulation Market by Application (Drug Discovery, Pre-Clinical, Clinical).
The report analyses the Biosimulation Market by End-User (Academic & Government Research Institutes, Pharmaceutical & Biotech Companies, Contract Research Organization, Regulatory Authorities).
The Global Biosimulation Market has been analysed by countries (United States, Canada, Mexico, Germany, United Kingdom, France, Italy, China, Japan, India).
The attractiveness of the market has been presented by region, by Component, Application and End-User.
Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include - Certara, Inc., Simulations Plus, Inc., Schrödinger, Inc., Dassault Systèmes, Physiomics plc, Thermo Fisher Scientific, Instem plc, Advanced Chemistry Development, Inc., Chemical Computing Group, Optibrium.

Key Target Audience

Pharmaceutical and Healthcare Companies
Pharmaceutical Research and Development Companies
Consulting and Advisory Firms
Government and Policy Makers
Regulatory Authorities

1. Introduction

1.1 Biosimulation Overview
1.2 Scope of Research

2. Executive Summary

2.1 Market Dashboard
2.2 Regional Insights
2.3 Market Ecosystem Factors

3. Research Methodology

3.1 Data Collection Process
3.2 Market Trajectory Estimation
3.3 Market Size Calculation

4. Market Dynamics

4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Trends
4.5 Impact assessment of Market Dynamics

5. Value Chain Analysis

5.1 Research and Development
5.2 Leading Developers and Providers
5.3 Top Ten Pharma Companies
5.4 End Use Industry

6. Covid-19 Impact Assessment

6.1 Assessment of Degree of Impact of Covid-19 on the Biosimulation Market
6.2 Region-Wise Quarterly Covid Impact Analysis

7. Porter's Five Forces Analysis

8. Macro Economic Indicator Outlook

8.1 Pharmaceutical Industry Growth
8.2 Global Healthcare Expenditure
8.3 Global Biopharma R&D Spending
8.4 Medicines in Development
8.5 Global Software Industry

9. Average Selling Price Analysis

9.1 Average Selling Price, By Region
9.2 Average Selling Price, By Component

10. Competitive Positioning

10.1 Companies Component Positioning
10.2 Market Position Matrix
10.3 Market Share Analysis
10.3.1 Certara, Inc.
10.3.2 Simulations Plus, Inc.
10.3.3 Schrˆdinger, Inc.
10.3.4 Dassault SystËmes
10.3.5 Physiomics plc
10.3.6 Thermo Fisher Scientific
10.3.7 Instem plc
10.3.8 Advanced Chemistry Development, Inc.
10.3.9 Chemical Computing Group
10.3.10 Optibrium

11. Global Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

11.1 Macro Economic Factor Impact Index
11.2 Global Biosimulation Market: Dashboard
11.3 Global Biosimulation Market Size, By Value, 2018-2021 (USD Million)
11.4 Global Biosimulation Market Size, By Value, 2022-2028 (USD Million)
11.5 Global Biosimulation Market: Summary

12. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Component

12.1 Global Biosimulation Market Trend And Forecast Analysis, By Component: Snapshot
12.2 Software
12.3 Service

13. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Application

13.1 Global Biosimulation Market Trend And Forecast Analysis, By Application: Snapshot
13.2 Drug Discovery
13.3 Pre-Clinical
13.4 Clinical

14. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By End-User

14.1 Global Biosimulation Market Trend And Forecast Analysis, By End-User: Snapshot
14.2 Academic & Government Research Institutes
14.3 Pharmaceutical & Biotech Companies
14.4 Contract Research Organization
14.5 Regulatory Authorities

15. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Region

15.1 Regional Coverage of the Study

16. Americas Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

16.1 Macro Economic Factor Impact Index
16.2 Impact analysis of market dynamics on Biosimulation Market
16.3 Americas Biosimulation Market: Dashboard
16.4 Americas Biosimulation Market Size, By Value, 2018-2021(USD Million)
16.5 Americas Biosimulation Market Size, By Value, 2022-2028 (USD Million)
16.6 Americas Biosimulation Market Trend And Forecast Analysis: Segmentation
16.6.1 By Component
16.6.2 By Application
16.6.3 By End-User
16.6.4 By Country
16.6.4.1 United States
16.6.4.2 Canada
16.6.4.3 Mexico
16.6.4.4 Rest of Americas

17. Europe Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

17.1 Macro Economic Factor Impact Index
17.2 Impact analysis of market dynamics on Biosimulation Market
17.3 Europe Biosimulation Market: Dashboard
17.4 Europe Biosimulation Market Size, By Value, 2018-2021(USD Million)
17.5 Europe Biosimulation Market Size, By Value, 2022-2028 (USD Million)
17.6 Europe Biosimulation Market Trend And Forecast Analysis: Segmentation
17.6.1 By Component
17.6.2 By Application
17.6.3 By End-User
17.6.4 By Country
17.6.4.1 Germany
17.6.4.2 United Kingdom
17.6.4.3 France
17.6.4.4 Italy
17.6.4.5 Rest of Europe

18. Asia Pacific Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

18.1 Macro Economic Factor Impact Index
18.2 Impact analysis of market dynamics on Biosimulation Market
18.3 Asia Pacific Biosimulation Market: Dashboard
18.4 Asia Pacific Biosimulation Market Size, By Value, 2018-2021(USD Million)
18.5 Asia Pacific Biosimulation Market Size, By Value, 2022-2028 (USD Million)
18.6 Asia Pacific Biosimulation Market Trend And Forecast Analysis: Segmentation
18.6.1 By Component
18.6.2 By Application
18.6.3 By End-User
18.6.4 By Country
18.6.4.1 China
18.6.4.2 Japan
18.6.4.3 India
18.6.4.4 Rest of APAC

19. Middle East & Africa Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

19.1 Impact analysis of market dynamics on Biosimulation Market
19.2 Middle East & Africa Biosimulation Market: Snapshot
19.3 Middle East & Africa Biosimulation Market Size, By Value, 2018-2021(USD Million)
19.4 Middle East & Africa Biosimulation Market Size, By Value, 2022-2028 (USD Million)
19.6 Middle East & Africa Biosimulation Market Trend And Forecast Analysis: Segmentation
19.6.1 By Component
19.6.2 By Application
19.6.3 By End-User

List of Figures

Figure 1: Biosimulation Market for next 7 years (in USD Millions)
Figure 2: Biosimulation Market Size, By Component, 2018 & 2028 (USD Million)
Figure 3: Biosimulation Market Size, Leading Application, 2021 (%)
Figure 4: Average Selling Price, By Region, 2021 (USD/One Time License)
Figure 5: Average Selling Price, By Component, 2021 (USD/One Time License)
Figure 6: Market Share of Prominent Companies of Biosimulation, 2021 (%)
Figure 7: Certara, Inc. Revenues, 2019-2021 (USD Million)
Figure 8: Certara, Inc. Revenue By Business Segment, 2021 (%)
Figure 9: Certara, Inc. Revenue By Geographic Segment, 2021 (%)
Figure 10: Simulations Plus, Inc. Revenues, 2019-2021 (USD Million)
Figure 11: Simulations Plus, Inc., Revenue By Business Segment, 2021 (%)
Figure 12: Simulations Plus, Inc., Revenue By Geographic Segment, 2021 (%)
Figure 13: Schrˆdinger, Inc. Revenues, 2019-2021 (USD Million)
Figure 14: Schrˆdinger, Inc. Revenue By Business Segment, 2021 (%)
Figure 15: Schrˆdinger, Inc. Revenue By Geographic Segment, 2021 (%)
Figure 16: Dassault SystËmes Revenues, 2019-2021 (USD Million)
Figure 17: Dassault SystËmes Revenue By Business Segment, 2021 (%)
Figure 18: Dassault SystËmes Revenue By Geographic Segment, 2021 (%)
Figure 19: Physiomics plc Revenues, 2019-2021 (USD Million)
Figure 20: Thermo Fisher Scientific Revenues, 2019-2021 (USD Million)
Figure 21: Thermo Fisher Revenue By Business Segment, 2021 (%)
Figure 22: Thermo Fisher Revenue By Geographic Segment, 2021 (%)
Figure 23: Instem plc Revenues, 2019-2021 (USD Million)
Figure 24: Instem plc Revenue By Business Segment, 2021 (%)
Figure 25: Instem plc Revenue By Geographic Segment, 2021 (%)
Figure 26: At a CAGR of 16.28% during 2023-2028, the global market value is expected to reach USD 8645.43 Million in 2028
Figure 27: Sales of Software is expected to contribute a share of 63.84% in 2021
Figure 28: Basis Point Analysis of Global Biosimulation Market, By Region (2022, 2028)
Figure 29: Market Opportunity Analysis of Global Biosimulation Market, By Region (2023-2028)
Figure 30: Global Biosimulation Market Size, By Value, 2018-2021(USD Million)
Figure 31: Global Biosimulation Market Size, By Value, 2022-2028 (USD Million)
Figure 32: Global Biosimulation Market Share, By Component, 2021 (%)
Figure 33: Global Biosimulation Market CAGR, By Component, By Value, 2018-2021, 2023-2028 (%)
Figure 34: Basis Point Analysis of Global Biosimulation Market, By Component (2022, 2028)
Figure 35: Market Opportunity Analysis of Global Biosimulation Market, By Component (2023-2028)
Figure 36: Global Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
Figure 37: Global Biosimulation Market Size, By Component, Software, By Value, 2022-2028 (USD Million)
Figure 38: Global Biosimulation Market Absolute Opportunity, By Component, Software, 2018-2028 (USD Million)
Figure 39: Global Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
Figure 40: Global Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 41: Global Biosimulation Market Absolute Opportunity, By Component, Service, 2018-2028 (USD Million)
Figure 42: Global Application Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 43: Basis Point Analysis of Global Biosimulation Market, By Application (2022, 2028)
Figure 44: Market Opportunity Analysis of Global Biosimulation Market, By Application (2023-2028)
Figure 45: Global Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
Figure 46: Global Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
Figure 47: Global Biosimulation Market Absolute Opportunity, By Application, Drug Discovery, 2018-2028 (USD Million)
Figure 48: Global Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
Figure 49: Global Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
Figure 50: Global Biosimulation Market Absolute Opportunity, By Application, Pre-Clinical, 2018-2028 (USD Million)
Figure 51: Global Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
Figure 52: Global Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
Figure 53: Global Biosimulation Market Absolute Opportunity, By Application, Clinical, 2018-2028 (USD Million)
Figure 54: Global End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 55: Basis Point Analysis of Global Biosimulation Market, By End-User (2022,2028)
Figure 56: Market Opportunity Analysis of Global Biosimulation Market, By End-User (2023-2028)
Figure 57: Global Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
Figure 58: Global Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
Figure 59: Global Biosimulation Market Absolute Opportunity, By End-User, Academic & Government Research Institutes, 2018-2028 (USD Million)
Figure 60: Global Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
Figure 61: Global Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2022-2028 (USD Million)
Figure 62: Global Biosimulation Market Absolute Opportunity, By End-User, Pharmaceutical & Biotech Companies, 2018-2028 (USD Million)
Figure 63: Global Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
Figure 64: Global Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
Figure 65: Global Biosimulation Market Absolute Opportunity, By End-User, Contract Research Organization, 2018-2028 (USD Million)
Figure 66: Global Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
Figure 67: Global Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
Figure 68: Global Biosimulation Market Absolute Opportunity, By End-User, Regulatory Authorities, 2018-2028 (USD Million)
Figure 69: Market Value of the Americas is expected to grow from USD 1448.02 MN in 2021 to USD 4236.26 Million in 2028
Figure 70: Americas Biosimulation Market is expected to foresee an absolute growth rate of 16.59% during 2023-2028
Figure 71: Market Value by Leading Component
Figure 72: Market Value by Leading Application
Figure 73: Top 3 End-User of Biosimulation
Figure 74: Basis Point Analysis of Americas Biosimulation Market, By Country (2022, 2028)
Figure 75: Market Opportunity Analysis of Americas Biosimulation Market, By Country (2023-2028)
Figure 76: Americas Biosimulation Market Size, By Value, 2018-2021 (USD Million)
Figure 77: Americas Biosimulation Market Size, By Value, 2022-2028 (USD Million)
Figure 78: Americas Biosimulation Market Share, By End-User, 2021 (%)
Figure 79: Americas Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 80: Basis Point Analysis of Americas Biosimulation Market, By Component (2022, 2028)
Figure 81: Market Opportunity Analysis of Americas Biosimulation Market, By Component (2023-2028)
Figure 82: Americas Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
Figure 83: Americas Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 84: Americas Component Software Footprint in Global Market, 2021 (% of Global Market)
Figure 85: Americas Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
Figure 86: Americas Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 87: Americas Component Service Footprint in Global Market, 2021 (% of Global Market)
Figure 88: Global Biosimulation Market Size, By End-User Energy, By Value, 2022-2028 (USD Million)
Figure 89: Basis Point Analysis of Americas Market, By Application (2022, 2028)
Figure 90: Market Opportunity Analysis of Americas, By Application (2023-2028)
Figure 91: Americas Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
Figure 92: Americas Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
Figure 93: Americas Application Drug Discovery Footprint in Global Market, 2021 (% of Global Market)
Figure 94: Americas Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
Figure 95: Americas Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
Figure 96: Americas Application Pre-Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 97: Americas Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
Figure 98: Americas Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
Figure 99: Americas Application Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 100: Americas End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 101: Basis Point Analysis of Americas Biosimulation Market, By End-User (2022, 2028)
Figure 102: Market Opportunity Analysis of Americas Biosimulation Market, By End-User (2023-2028)
Figure 103: Americas Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
Figure 104: Americas Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
Figure 105: Americas End-User Academic & Government Research Institutes Footprint in Global Market, 2021 (% of Global Market)
Figure 106: Americas Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
Figure 107: Americas Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, By Value, 2022-2028 (USD Million)
Figure 108: Americas End-User Pharmaceutical & Biotech Companies Footprint in Global Market, 2021 (% of Global Market)
Figure 109: Americas Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
Figure 110: Americas Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
Figure 111: Americas End-User Contract Research Organization Footprint in Global Market, 2021 (% of Global Market)
Figure 112: Americas Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
Figure 113: Americas Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
Figure 114: Americas End-User Regulatory Authorities Footprint in Global Market, 2021 (% of Global Market)
Figure 115: United States Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 116: United States Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 117: United States Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 118: United States Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 119: United States Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 120: United States Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 121: Canada Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 122: Canada Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 123: Canada Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 124: Canada Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 125: Canada Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 126: Canada Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 127: Mexico Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 128: Mexico Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 129: Mexico Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 130: Mexico Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 131: Mexico Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 132: Mexico Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 133: Rest of Americas Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 134: Rest of Americas Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 135: Rest of Americas Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 136: Rest of Americas Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 137: Rest of Americas Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 138: Rest of Americas Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 139: Market Value of the Europe is expected to grow from USD 801.96 MN in 2021 to USD 2217.55 MN in 2028
Figure 140: Europe Biosimulation Market is expected to foresee an absolute growth of 15.65 % during 2023-2028
Figure 141: Market Value by Leading Component
Figure 142: Market Value by Leading Application
Figure 143: Top 3 End-User of Biosimulation
Figure 144: Basis Point Analysis of Europe Biosimulation Market, By Country (2022, 2028)
Figure 145: Market Opportunity Analysis of Europe Biosimulation Market, By Country (2023-2028)
Figure 146: Europe Biosimulation Market Size, By Value, 2018-2021 (USD Million)
Figure 147: Europe Biosimulation Market Size, By Value, 2022-2028 (USD Million)
Figure 148: Europe Biosimulation Market Share, By End-User, 2021 (%)
Figure 149: Europe Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 150: Basis Point Analysis of Europe Biosimulation Market, By Component (2022, 2028)
Figure 151: Market Opportunity Analysis of Europe Biosimulation Market, By Component (2023-2028)
Figure 152: Europe Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
Figure 153: Europe Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 154: Europe Component Software Footprint in Global Market, 2021 (% of Global Market)
Figure 155: Europe Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
Figure 156: Europe Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 157: Europe Component Service Footprint in Global Market, 2021 (% of Global Market)
Figure 158: Europe Application Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 159: Basis Point Analysis of Europe Market, By Application (2022, 2028)
Figure 160: Market Opportunity Analysis of Europe, By Application (2023-2028)
Figure 161: Europe Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
Figure 162: Europe Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
Figure 163: Europe Application Drug Discovery Footprint in Global Market, 2021 (% of Global Market)
Figure 164: Europe Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
Figure 165: Europe Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
Figure 166: Europe Application Pre-Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 167: Europe Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
Figure 168: Europe Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
Figure 169: Europe Application Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 170: Europe End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 171: Basis Point Analysis of Europe Biosimulation Market, By End-User (2022, 2028)
Figure 172: Market Opportunity Analysis of Europe Biosimulation Market, By End-User (2023-2028)
Figure 173: Europe Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
Figure 174: Europe Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
Figure 175: Europe End-User Academic & Government Research Institutes Footprint in Global Market, 2021 (% of Global Market)
Figure 176: Europe Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
Figure 177: Europe Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, By Value, 2022-2028 (USD Million)
Figure 178: Europe End-User Pharmaceutical & Biotech Companies Footprint in Global Market, 2021 (% of Global Market)
Figure 179: Europe Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
Figure 180: Europe Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
Figure 181: Europe End-User Contract Research Organization Footprint in Global Market, 2021 (% of Global Market)
Figure 182: Europe Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
Figure 183: Europe Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
Figure 184: Europe End-User Regulatory Authorities Footprint in Global Market, 2021 (% of Global Market)
Figure 185: Germany Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 186: Germany Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)

Table Information

Report Attribute	Details
No. of Pages	270
Published	November 2022
Forecast Period	2022 - 2028
Estimated Market Value ( USD ) in 2022	$ 3.49 Billion
Forecasted Market Value ( USD ) by 2028	$ 8.64 Billion
Compound Annual Growth Rate	16.3%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2360EUR$2,400USD£1,946GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€2951EUR$3,000USD£2,432GBP

Scope of the Report

Key Target Audience

Table of Contents

Table Information

Related Topics

Related Reports

Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply Chain: Planning & Forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029

Biosimulation Global Market Report 2024

Biosimulation Market by Offering, Delivery Model, End-User, Application - Global Forecast 2025-2030

Biosimulation Market

Biosimulation Market Report and Forecast 2024-2032